StemCells, Inc. to Participate at the Inaugural World Medical Innovation Forum
27. April 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, CEO of StemCells, Inc., will participate on a panel moderated by Alice Park,...
StemCells, Inc. Announces Pricing of Public Offering to Raise $25 Million
24. April 2015 09:25 ET
|
StemCells, Inc.
NEWARK, Calif., April 24, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the pricing of an underwritten public offering of common stock and warrants with a public offering...
StemCells, Inc. Announces Proposed Public Offering of Common Stock and Warrants
23. April 2015 16:14 ET
|
StemCells, Inc.
NEWARK, Calif., April 23, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it intends to offer and sell common stock and warrants, subject to market and other conditions, in...
StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury
16. April 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., April 16, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for treating diseases of the central nervous...
StemCells, Inc. to Participate at the 14th Annual Needham Healthcare Conference
07. April 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn, CEO of StemCells, Inc., will make a presentation on the Company's programs and...
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
24. März 2015 10:34 ET
|
StemCells, Inc.
NEWARK, Calif., March 24, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
StemCells, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Update
16. März 2015 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics for diseases of the central...
StemCells, Inc. to Participate at the Wall Street Analyst Forum 25th Annual Institutional Investor Conference
10. März 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., March 10, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the Wall Street...
StemCells, Inc. Announces Webcast to Discuss Fourth Quarter and Full Year 2014 Financial Results
09. März 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
Safety and Preliminary Efficacy of Human Neural Stem Cells in StemCells, Inc.'s Dry AMD Study to be Presented at Ophthalmology Conference
05. Februar 2015 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...